Prostatis Group’s SPDR Gold Trust GLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.08M Sell
18,776
-596
-3% -$267K 2.07% 8
2025
Q4
$7.68M Buy
19,372
+455
+2% +$174K 1.83% 10
2025
Q3
$6.72M Buy
18,917
+2,611
+16% +$832K 1.69% 13
2025
Q2
$4.97M Buy
16,306
+2,516
+18% +$762K 1.42% 17
2025
Q1
$3.97M Sell
13,790
-7,184
-34% -$1.9M 1.25% 15
2024
Q4
$5.08M Buy
20,974
+2,204
+12% +$542K 1.48% 17
2024
Q3
$4.56M Sell
18,770
-410
-2% -$93.9K 1.49% 13
2024
Q2
$4.17M Buy
19,180
+275
+1% +$59.5K 1.46% 14
2024
Q1
$3.9M Sell
18,905
-158
-0.8% -$30.3K 1.48% 17
2023
Q4
$3.64M Buy
19,063
+982
+5% +$180K 1.52% 17
2023
Q3
$3.08M Sell
18,081
-1,558,091
-99% -$279M 1.51% 14
2023
Q2
$3.84M Buy
1,576,172
+1,559,862
+9,564% +$287M 1.78% 13
2023
Q1
$3.04M Buy
16,310
+4,686
+40% +$825K 1.61% 16
2022
Q4
$1.97M Buy
11,624
+4,841
+71% +$780K 1.2% 26
2022
Q3
$1.05M Buy
+6,783
New +$1.09M 1.21% 23
2022
Q2
Sell
-3,538
Closed -$639K 62
2022
Q1
$639K Buy
+3,538
New +$621K 0.51% 40

Other funds holding GLD

Prostatis Group's GLD Position: Q1 2026 in Review

Prostatis Group reduced its SPDR Gold Trust (GLD) stake by 3.1% in Q1 2026, selling an estimated $267K and leaving 18,776 shares worth $8.08M. The position accounts for 2.07% of the portfolio, ranked #8.

Prostatis Group first reported a position in GLD in Q1 2022 and has held it in 16 quarters since. 3,144 funds tracked by Wall St. Rank hold GLD as of Q1 2026.

  • Prostatis Group held 18,776 shares of SPDR Gold Trust worth $8.08M as of Q1 2026.
  • Prostatis Group sold 596 SPDR Gold Trust shares in Q1 2026, an estimated $267K.
  • SPDR Gold Trust made up 2.07% of Prostatis Group's portfolio in Q1 2026, its #8 holding.
  • Prostatis Group first reported a position in SPDR Gold Trust in Q1 2022 and has held it in 16 quarters since.
  • 3,144 funds tracked by Wall St. Rank held SPDR Gold Trust as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.